SAGICO will be represented at the 37th Annual J.P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, in San Francisco, California.
TAMPA, Fla. (PRWEB) January 08, 2019
Spinal Analytics & Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that SAGICO will be represented at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry and brings together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
The annual J.P. Morgan Healthcare Conference began in 1983 and, at its infancy, featured just 20 companies with approximately 200 attendees focused on the biotech industry. Today, the premier conference brings thousands of investors from around the world together. The conference is expected to attract over 9,000 attendees and over 450 companies from all spectrums of healthcare .The companies presenting run the gamut from start-ups to those with more than $300 billion in market cap and encompass the entire global healthcare landscape. Participants include pharmaceutical firms, healthcare service providers, profit and not-for-profits entities, and medical device companies.
MORE ABOUT SAGICO: SAGICO’s IBF System is the company’s flagship line and is comprised of the ARIA Lumbar and the ARION Cervical, both expandable interbody fusion device comprised primarily of PEEK biomaterials with unique first-to-market features and proven spinal implant technology. The Aria Lumbar and Arion Cervical, with several thousand implants successfully performed in various parts of the world, are now available to surgeons in the USA as a limited market release. ARION's 5° lordosis is a unique stand-alone cervical implant, featuring TriFix Technology, comprised of three points of contact offering superior fixation without the need for anterior plate or screws while offering increased options for cervical spinal fusion. The Arion 5° lordosis is the first and only in the market available with posterior expansion and fixation.
The unique construction of Aria Lumbar offers surgeons a superior option for spinal fusion surgery without many of the challenges associated with the surgical procedure. The controlled incremental expansion is designed to allow surgeons the ability to restore disc height and optimize the implant specifically for each patient. Aria Lumbar offers surgeons a unique cutting-edge implant design with multiple height and lordotic options, which will offer surgeons surgical solutions to help achieve optimal sagittal balance in patients in a time efficient OR.
SAGICO accomplishes its mission with partners throughout the USA, European and PanAsian markets. SAGICO and its affiliates are privately held companies with global partners and shareholders and an aggressive pipeline that includes: novel artificial disk implants (TDR), Porous Titanium interbody technology, Expandable VBR options and unique Pedicle Screw Systems optimized for Complex & Pediatric surgery are just a few of the product lines SAGICO offers. SAGICO’s USA corporate based operations, are located in Tampa, Florida.
DISCLOSURE: We at SAGICO are confident in our products and so should our professional surgeons. A surgeon must always rely on his or her own clinical judgment when deciding whether to use a particular medical appliance that may be applicable for a specific patient and adhere to the package insert, product label and/or instructions for use before using any SAGICO product. SAGICO does not diagnose nor does SAGICO offer medical advice on medical conditions and SAGICO requires that all surgeons be trained in the use of any particular product before using it in surgery. The information presented is intended to demonstrate the depth and future of all of SAGICO’s product lines. Some products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact SAGICO prior to any medical procedures to learn more.